A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection (Q30437722)

18 August 2017

A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection (English)

1 reference

18 August 2017

Clostridium difficile

0 references

1 reference

Mary Y Hu

1

1 reference

18 August 2017

Seema Maroo

2

1 reference

18 August 2017

Lorraine Kyne

3

1 reference

18 August 2017

Jeffrey Cloud

4

1 reference

18 August 2017

Sanjeev Tummala

5

1 reference

18 August 2017

Kianoosh Katchar

6

1 reference

18 August 2017

Valley Dreisbach

7

1 reference

18 August 2017

Laura Noddin

8

1 reference

18 August 2017

Ciarán P Kelly

9

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Clinical Gastroenterology and Hepatology

18 August 2017

1 reference

18 August 2017

6

1 reference

18 August 2017

12

1 reference

18 August 2017

1354-1360

1 reference

Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-rep

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

An epidemic, toxin gene-variant strain of Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Factors associated with failure of metronidazole in Clostridium difficile-associated disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Clostridium difficile colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2644212

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19081526

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19081526

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19081526

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CGH.2008.06.024

1 reference

18 August 2017

1 reference

18 August 2017

1 reference